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1.  ABBREVIATIONS 
 
ACE    angiotensin-converting enzyme 
ALRI   acute lower respiratory infection 
BPD   bronchopulmonary dysplasia 
CBMC  cord blood mononuclear cell 
CTL    cytotoxic T lymphocyte 
CTLA-4  cytotoxic T lymphocyte antigen 4 
DC   dendritic cell 
EOS   early onset neonatal sepsis 
G-CSF  granulocyte colony-stimulating factor 
GM-CSF   granulocyte-macrophage colony-stimulating factor 
GST    glutathione S transferase 
HDM   house dust mite 
HEV   high endothelial venules 
IFN-a   Interferon alpha 
IFN-g   Interferon gamma 
iNKT   invariant natural killer T cell 
mDC   myeloid dendritic cell 
MHC   major histocompatibility complex 
NEC   necrotising enterocolitis 
NETs    neutrophil extracellular traps 
NICU   neonatal intensive care unit 
NK   natural killer cell 
NP   normal pregnancy 
OVA   ovalbumine 
PAMPs   pathogen-associated molecular patterns on microbes 
pDC   plasmacytoid dendritic cell 
PE   preeclampsia 
PPHN   persistent pulmonary hypertension of the neonate 
PROM  premature rupture of membranes  
DOI:10.14753/SE.2017.2025
5 
PS   prenatal steroid 
RDS   respiratory distress syndrome 
RSV   respiratory syncytial virus 
TCR   T cell receptor 
TGF-b  tumor growth factor beta 
TLR9   toll-like receptor 9 
TNF   tumor necrosis factor 
TNF-alpha-238 tumor necrosis factor-alpha-238 
Treg   regulatory T cell 
Th1/Th2  T helper 1/ T helper 2 cells 
TTN   transitory tachypnea of the neonate 
VDR   vitamin D receptor 
VLBW  very low birth weight 
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2.  INTRODUCTION 
 
 Preterm birth, defined as birth at less than 37 completed weeks of gestation, 
occurs in around 12% of deliveries worldwide with major implications for the long term 
health of the child. Mortality rates of preterm infants have decreased substantially over 
the last few decades due to advances in medical care system. However, morbidity rates, 
particularly in the very preterm infant (born less than 28 weeks of gestation) have 
continued to rise [1].  
  
 On the long term, preterm infants who survive may suffer from permanent 
disabilities due to organ damage resulting from either an infection or from the systemic 
inflammatory response triggered by different factors [2]. In these vulnerable preterm 
infants, early diagnosis of the inflammatory response is critical and can set the stage for 
lifelong morbidities [3]. 
  
 Our research group has a longstanding interest in the investigation of the 
neonatal and preterm immune response and function. The results obtained in such 
studies do not only help us better understand the basic principles of the development of 
the human adaptive immune system, but also play a key role in identifying diagnostic 
and therapeutic targets that may provide better care for this vulnerable population in the 
very near future. 
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2.1.  THE NEONATAL IMMUNE SYSTEM 
 
 Normal term neonates rely heavily on their immune system at birth to fight 
infection in the pathogen-prone extrauterine environment, however it is still not fully 
developed (Figure 1.) [4]. 
  Preterm infants have an under-developed immunoregulatory system, therefore 
there is the potential for chronic inflammation to develop [5]. For instance, the immune 
system of preterm infants has a smaller prevalence of monocytes and neutrophils, 
impaired ability of these cells to kill pathogens, and lower production of cytokines 
which limits T cell activation and reduces the ability to fight bacteria and detect viruses 
in cells, compared to term infants. Intrauterine inflammation is a major contributor to 
preterm birth, and causes premature immune activation and cytokine production. This 
can induce immune tolerance leading to reduced newborn immune function [6]. 
 
 
Figure 1. Leukocyte development begins in the yolk sac before moving to the liver and 
finally to the bone marrow. The development and maturation of primary lymphoid 
organs (blue) and peripheral blood leukocytes (red) occur throughout gestation but is 
not complete until after birth. The light gray shading shows the gestational ages of 
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preterm births from the threshold of viability (24 weeks; at which 50% of infants in 
developed countries survive) to 37 weeks of gestation [7]. 
 
 Both the innate and adaptive immunity are compromised in preterm neonates, and 
they also have deficiencies in the interaction between these two systems [7-8]. 
 
 2.1.1. The innate immune system of preterm neonates 
 
 The innate immune response of preterm infants is diminished in its potential to 
adequately respond to infections due to deficiencies in the soluble protein/peptide and 
cellular responses to infection. 
Phagocytes include neutrophils, monocytes/macrophages and dendritic cells (DCs). 
Preterm infants have a reduced prevalence of neutrophils and monocytes, and their 
precursors, due to reduced granulocyte colony-stimulating factor (G-CSF) and 
granulocyte-macrophage colony-stimulating factor (GM-CSF) levels [9]. 
Neutrophils are among the first responders to infection and have an important role in 
bacterial clearance [10]. Neutrophils of preterm infants may have difficulty in migrating 
to sites of infection due to a reduction in the expression of adhesion molecules such as 
L- and E-selectin [11]. Impairment in neutrophil function (phagocytosis, generation of 
oxygen radicals and intracellular killing of pathogens) is a risk factor for the 
development of sepsis [12]. Extracellular pathogen killing is also limited in neonates, 
with reduced ability to produce neutrophil extracellular traps (NETs) [13]. NETs are 
lattices made of DNA bound to granular and cytoplasmic protein, which are released 
from neutrophils to trap and kill pathogens [14]. 
Monocytes are phagocytic blood-borne cells that differentiate into macrophages or DCs 
in tissue. Monocytes are capable of phagocytosis, have bactericidal mechanisms and are 
involved in antigen presentation to T cells [10]. The monocytes of preterm infants have 
reduced cytokine production, but a similar efficiency in phagocytosis and intracellular 
killing of pathogens as term neonates [15]; however, they may be limited in their ability 
to activate the adaptive immune response because major histocompatibility complex 
(MHC) class II expression is reduced on leukocytes from preterm neonates [16], thus 
limiting their ability to present antigen to T cells and activate them. 
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 2.1.2. The adaptive immune system of preterm neonates 
 
 Adaptive immunity, which involves B and T lymphocytes, is pathogen-specific 
and requires acquisition of immunological memory. 
At birth, lymphocyte subpopulations in term infants are lower when compared to adults. 
Moreover, maturation of adaptive immunity occurs mostly after term birth, suggesting 
that most newborn infants have deficiencies in T cell activation and cytokine 
production, B cell immunoglobulin production, and interactions between T and B cells, 
when compared to adults [6, 17]. A few studies showed that lymphocyte subpopulations 
are reduced in children born preterm at 7 months [18] and 8 years [19] of age, compared 
to age-matched children born at term. 
 Cell-mediated immunity involves two main types of T cells, cytotoxic T 
lymphocytes (CTL; CD8+) and T helper lymphocytes (Th; CD4+). CD8+ CTLs are 
involved in the eradication of intracellular pathogens such as viruses and are presented 
antigen by APCs expressing MHC class I. CD4+ T helper cells, activated by MHC II, 
are further divided into Th1 and Th2 CD4+ cells, defined by their cytokine profile. The 
Th1 phenotype is often classed as inflammatory, producing the cytokines interferon-γ 
(IFN-γ), interleukin (IL)-2 and tumor necrosis factor-α (TNF-α). The Th2 phenotype is 
anti-inflammatory, producing cytokines such as IL-4, IL-5, IL-13, and IL-10 [6]. 
Recently, two further types of T helper cytokines have been characterized. Th17 cells, 
producing IL-17, also have strong pro-inflammatory properties and play a role in the 
development of autoimmunity. On the other hand, regulatory T cells (Tregs) have the 
potential to suppress the above subsets, commonly known as effector T cells. An 
important transcription factor for the development of Tregs is FoxP3 [6]. 
Preterm and term neonates have deficient T cell function as a result of a greater 
proportion of naïve T cells in the circulation and a low subpopulation of memory T cells 
[17]. The increased proportion of naive T cells is a result of inefficient DC antigen 
uptake and presentation, and is contributed to by a reduction in MHC II expression on 
antigen-presenting cells [8]. 
Cytokine responses are driven toward a Th2 phenotype during fetal life (Figure 2). The 
Th2 bias is believed to be a preventative measure against fetal rejection by the maternal 
immune system, with increased Th1 cytokine production linked to an increased risk of 
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spontaneous abortion [6]. Preterm and term neonates are believed to be vulnerable to 
infection due to this bias toward a Th2 CD4+ T cell phenotype and as a result have 
lower production of cytokines such as IFN-γ in comparison to adults, which can result 
in deficient viral detection and clearance [4]. 
 
 
 
Figure 2. Developmental changes occurring in the human immune system early in 
life. This figure illustrates maturational events occurring in major adaptive and innate 
immune functions as the human being transitions from a fetal tolerance state and 
becomes exposed to microorganisms as well as other environmental antigens de novo 
after birth. Adaptive immune functions [top panel]: Maternal transplacental antibody 
transfer (IgG) mainly occurs during late gestation, followed by maternal antibody 
protection (e.g. IgA) acquired through breast-milk after birth. Infants' own antibody 
response becomes fully mature later during early childhood. Neonatal T cells are 
largely biased towards helper type II responses and humans display high proportions of 
T regulatory and natural killer T cells at birth [20]. Innate immune functions [bottom 
panel]: Pro-inflammatory (IL-1β, IL-6, TNF-α, IL-12, IL-23) and anti-viral (IFN-α) 
cytokine responses are largely attenuated in preterm infants, whereas production of the 
anti-inflammatory IL-10 cytokine is high during late gestation and at birth [2]. 
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2.2. INFLAMMATORY DISORDERS IN THE NEONATE 
 
 Several inflammatory disorders have been described in neonates which lead to 
an exaggerated release of inflamatory mediators, amongst the most important and 
common are BPD, NEC and sepsis. These disorders also have a multi-factorial 
pathogenesis [21]. 
 
 2.2.1. Bronchopulmonary dysplasia (BPD) 
 
 BPD is a disorder of prematurity characterised by the need for assisted ventilation 
or supplemental oxygen at 36 weeks postmenstrual age and signs of impaired 
alveolarisation and vasculogenesis in the lungs. BPD occurs in approximately 45% of 
infants born less than 29 weeks gestation that survive preterm birth [5, 22]. Ongoing 
lung damage may be caused by the preterm infant's inability to down-regulate and 
maintain control of the inflammatory immune response, leading to a chronic 
inflammatory state [5, 22-24]. Figure 3. shows general critical steps and associated 
mediators in lung inflammation, injury and remodelling that lead to BPD. 
Several biomarkers have been described to be involved in the development of BPD, 
such as chemokines, adhesion molecules, pro-inflammatory cytokines, growth factors 
and others. 
IL-8 (also called CXCL8) is the chemokine that has been investigated most extensively 
in preterm infants. Increased concentrations of IL-8 precede neutrophil infiltration in 
tracheal aspirates from preterm infants as well as in infants ventilated with high tidal 
volumes. Other chemokines associated with the development of BPD include the 
monocyte chemoattractant proteins, MCP-1 (CCL2), MCP-2 (CCL8) and MCP-3 
(CCL7), and macrophage inflammatory proteins, MIP-1a (CCL3) and MIP-1b (CCL4). 
In addition to an association with BPD, increased concentrations of MCP-1 in airway 
secretions have been observed in the presence of tracheal colonisation with Ureaplasma 
urealyticum, a putative risk factor for BPD [23]. 
Adhesion molecules include selectins, responsible for transient adhesion and rolling, 
and integrins and immunoglobulins, responsible for firm adhesion and transmigration. 
These proteins appear to be critical in the development of parenchymal damage in 
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infants with BPD [23]. 
The common pro-inflammatory cytokines TNF-α, IL-1, IL-6 and IL-8 are the most 
extensively studied cytokines in this category, and are important biomarkers for the 
prediction of adverse pulmonary outcomes in preterm infants. Increased concentrations 
of IL-1, TNF-α, IL-6 and IL-8 correlate with the duration of supplemental oxygen and 
mechanical ventilation and are increased in infants who develop BPD compared with 
infants of similar gestational age who do not develop BPD [25]. 
Recently, genetic susceptibility for BPD has also been reported as a potential factor in 
the pathogenesis. There have been several studies addressing the association of 
polymorphisms in genes, such as angiotensin-converting enzyme (ACE), glutathione S 
transferase (GST) and TNF-alpha 238, with the development of BPD [22, 26-28]. Twin 
studies have revealed that the BPD status of one twin, even after correcting for 
contributing factors, is a highly significant predictor (53%) of BPD in the second twin 
[29].  
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Figure 3. Diagram representing critical steps and associated mediators in lung 
inflammation, injury and remodelling that result in BPD [23]. 
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 2.2.2. Necrotising enterocolitis (NEC) 
 
 NEC is predominantly a disease of prematurity, it is the most common 
gastrointestinal illness in newborns, and remains a major cause of neonatal morbidity 
and death (15%–25%) [21, 30-31]. Due to the multifactorial etiology (Figure 4.), early 
diagnosis and effective treatment of NEC is limited. Consequently, many cases, 20% to 
40% of patients, require surgical intervention [32]. 
Up to date, several in vitro and in vivo experiments have been developed in order to 
understand the immune mechanisms of NEC. Most of the studies are using animal 
models due to the limitations of access to human preterm infants’ samples. 
Current evidence suggests that NEC is due to the dysfunction of the intestinal mucosal 
barrier and an inappropriate inflammatory response of the immature gut. As the disease 
progresses, inflammation in the intestine worsens causing breakdown of the mucosal 
barrier and an escalating immune cascade leading to sepsis, shock and even death [30-
31]. The risk for developing NEC is strongly influenced by commensal bacteria, which 
exert metabolic, nutritional and immunological effects on the host [18]. For instance, 
high TLR-4 expression has been associated with human NEC [33]. Toll-like receptors 
(TLRs) are membrane spanning receptors that recognize pathogen-associated molecular 
patterns on microbes (PAMPs) once they have breached the physical barriers, such as 
the mucosal layer, and therefore play a key role in the innate immune system [34]. 
 
Figure 4. Possible mechanisms involved in the pathogenesis of NEC [35]. 
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 2.2.3. Sepsis 
 
 Sepsis is a systemic inflammation caused by infection that may occur in infants 
throughout the whole neonatal period. Globally, sepsis is responsible for approximately 
15% of neonatal deaths [36], with rates of infection dependent on the geographic region. 
In preterm and term infants, sepsis is classified as either early-onset (<72 h of life) or 
late-onset (>72 h of life), with the latter being a common complication associated with 
prolonged admission to the neonatal intensive care unit (NICU). The distinction 
between the two is of clinical importance, as early-onset sepsis usually results from 
exposure to bacteria in utero or during delivery and late-onset sepsis is acquired from 
bacteria in the environment (like nosocomial infections) [37-38]. Therefore, the choice 
for empirical antibiotic treatment is different in clinical practice. 
 In the early state of sepsis, the excessive activation of the antigen recognition 
system and the release of pro-inflammatory mediators lead to serious multisystem 
dysfunction in the body. During sepsis, microbes or necrotic tissue release high levels of 
harmful substances, resulting in the activation of the systemic immune response and 
excessive activation of immune cells. The excessive release of pro-cytokines plays a 
destructive effect. The uncontrolled inflammatory cascade may lead to endothelial 
dysfunction, resulting in life-threatening conditions, such as shock and hypotension. 
T cells, especially Th1 and Th2 cells, play an important role in the regulation of 
inflammation. In the pathogenesis of sepsis, the acquired immune response is 
transformed from the Th1 cell-mediated immune response (characterized by the 
production of IFN-γ and IL-12) into the Th2 cell-mediated immune response 
(characterized by the production of IL-4, IL-5, IL-10 and IL- 13), leading to further 
immune suppression. In addition, the increased rate of apoptosis of lymphocytes and 
DCs also plays an important role in immune suppression. In contrast, apoptosis of 
macrophages and neutrophils is decreased rather than increased [39-40], further 
promoting inflammation. Early T cell-mediated innate immune suppression is reported 
to reduce the septic damage [41]. There is evidence that sepsis does not only affect the 
body's immune system but also acts on the body's coagulation system and the 
autonomic nervous system [42-43]. 
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2.3.  PERINATAL AND POSTNATAL COMPLICATIONS 
  
 A variety of prenatal factors and events may lead to preterm birth, further 
modulating and compromising the immune system of the newborn. A better 
understanding of perinatal complications which affect the newborn's immune status will 
therefore allow for a further refinement of care leading to a reduction of lifelong adverse 
immune consequences. Several research groups, including ours, aimed to describe the 
immunologic effects of perinatal complications that lead to preterm birth and severely 
affect the immune system of the newborn. 
 Amongst the most important complications during pregnancy are hypertensive 
disorders, such as preeclampsia (PE), gestational diabetes, premature rupture of 
membranes (PROM) and of vitamin D deficiency [44-45]. These perinatal 
complications seem to have a serious impact on different immune cell subpopulations, 
cytokines and lymphocyte activation markers in the maternal and fetal immune system. 
The use of antenatal steroid prophylaxis for the prevention of surfactant deficiency and 
respiratory distress syndrome (RDS) may also have long-term consequences on 
neonatal immunity. 
 
 2.3.1. The role of vitamin D levels at birth in preterm infants 
 
 Vitamin D (25(OH)D) is a steroid hormone essential for the regulation of a large 
number of physiological processes such as calcium homeostasis, muscle and bone 
health. Low serum vitamin D concentrations (that are directly correlated with maternal 
vitamin D status at birth) are common in preterm infants during birth, hospitalisation 
and at discharge from the neonatal intensive care unit [46-47]. Different studies and 
organizations have recommended vitamin D intake of 400 IU/day to achieve a target 
serum 25 (OH)D concentration above 20 ng/mL for all infants [47-48]. 
 Vitamin D has an important role in the control of inflammatory responses [49]. 
Recently, it was found that severely low maternal and neonatal 25(OH)D levels are 
associated with early-onset neonatal sepsis (EOS) [50]. Subclinical vitamin D 
deficiency in neonates is associated with diminished immune function and increases the 
risk of Th1 autoimmune diseases like type 1 diabetes [51] and is also associated with an 
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increased risk of acute lower respiratory infections (ALRI) [52]. Low cord blood 
vitamin D status was also found to be associated with higher risk of milk sensitization 
during early childhood [53]. 
Active form of the vitamin (1,25(OH)2D3) regulates the growth and differentiation of 
multiple immune cell types, and displays immunoregulatory and anti-inflammatory 
properties (Figure 5.) [54].  
 
 
 
Figure 5. Mechanisms by which 25(OH)D and 1,25(OH)2D3 modulate innate and 
adaptive immune responses. All these cells possess the enzyme (CYP27bB1) for 
hydroxylation steps to generate 1,25(OH)2D3. Through endocrine, intracrine and 
paracrine mechanisms, the active form of vitamin D binds to the vitamin D receptor 
(VDR) to induce a wide range of immunological effects [55-56]. 
 
 1,25(OH)2D3 inhibits several components of the immune system [57], including 
DC differentiation and maturation as well as modulation of their activation and survival 
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leading to T cell hyporesponsiveness (Figure 6.) [58]. 1,25(OH)2D3 was also shown to 
play an important role in the maintenance of B cell homeostasis and differentiation [59] 
and T cell proliferation in response to T cell receptor stimulation [60]. A more recent 
study [61] demonstrated that vitamin D impairs the capacity of murine and human 
plasmacytoid dendritic cells (pDCs) to induce T cell proliferation and secretion of the T 
helper 1 cytokine IFN-γ. The inhibitory effect of vitamin D was found to be dependent 
on the expression of its receptor (VDR) in DCs. Subsequent human and animal model 
studies also demonstrated that 1,25(OH)2D3 acts directly on T cells to promote FoxP3+ 
and IL-10+ Tregs, secretion of the immunomodulatory cytokines IL-10 and TGF-β, and 
upregulation of the inhibitory molecule cytotoxic T lymphocyte antigen (CTLA)-4 on 
the cell surface [62]. 
 
 
 
Figure 6. Overview of immunomodulatory actions of 25(OH)D3 and 1,25(OH)2D3 on 
monocytes and macrophages, dendritic cells, effector, and memory T and B 
lymphocytes [55-56]. 
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 2.3.2. The impact of preeclampsia in preterm neonates 
 
 Balanced immune responses are required for the maintenance of a successful 
pregnancy in order to avoid adverse pregnancy outcomes, such as preeclampsia (PE) 
and miscarriage [63]. To date, there is very limited information about the impact of 
maternal PE on the fetal immune system. PE is a multisystem, highly variable disorder 
unique to pregnancy and a major cause of maternal and fetal/neonatal morbidity and 
mortality [64].  
 PE has been reported with an incidence of 6% to 10% [65]. The majority of 
cases happen to occur in healthy nulliparous women with a reported incidence of 10% 
to 12% [66-67]. The rates are even higher in women with certain risk factors, such as 
multifetal gestation (25-30%), PE in previous pregnancy (20-50%), women with 
preexisting chronic hypertension (15-50%), pregestational diabetes mellitus (15-35%), 
renal disease, or thrombophilia [65, 68]. 
PE is characterized as either a maternal syndrome (hypertension and proteinuria with or 
without other multisystem abnormalities), or a fetal syndrome (the inability of the 
trophoblast to invade the decidual arteries leading to alterations in placental 
development, placental perfusion, insufficient transport of nutrients and abnormal 
oxygenation) [68-69]. 
Activation of the maternal innate and adaptive immune system plays an essential role in 
the pathophysiology of PE (Figure 7.). Activated neutrophils, monocytes, and natural 
killer (NK) cells initiate inflammation, which induces endothelial dysfunction, and 
activated T cells may support inadequate tolerance during pregnancy [70]. 
In healthy non-pregnant women, there is a balance between Th1 and Th2 responses 
[71]. However, many authors observed Th1/Th2 immunity alterations with a shift to a 
predominantly Th2 type immunity during normal pregnancy (NP) [72]. This alteration 
might be due to the development of the placenta, since its production of progesterone 
and cytokines may gear the immune cells to a Th2 response [73]. The anti-inflammatory 
Th2 reaction is crucial for tolerance to the fetus, decidualization and remodelling. 
The pro-inflammatory Th1 immune response is responsible for extravillous trophoblast 
invasion, parturition and host defence in NP [64]. In contrast, several groups reported 
that PE is associated with pathological Th1 type immunity which also impairs maternal 
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tolerance to the fetus [74-77]. However, it still remains unclear which factors influence 
Th1/Th2 imbalance in PE.  
Th17 and Treg cells have also been suggested to be of importance in the development of 
maternal systemic inflammation in PE [78]. The frequency of Th17 cells was found to 
be elevated in the peripheral blood of PE patients compared to NP women in the third 
trimester of pregnancy [79-80]. A number of groups, including ours, demonstrated that 
the prevalence of peripheral Tregs is lower in PE compared to healthy pregnancy [70, 
81-84]. 
Furthermore, it was found that NK cells are also involved in PE. Several groups showed 
that the numbers of NK cells are either increased or decreased in PE women [85-86] 
when compared to NP. The conflicting results may be due to different methods of 
isolation and the location of sampling (ie. peripheral blood or placenta). Moreover, the 
NK1/NK2 and NKT1/NKT2 cell ratios were found to be significantly decreased in 
normal pregnancy compared with non-pregnant and PE women [87]. 
Several studies have shown that the neonatal outcome of PE mothers is often 
complicated by severe clinical features, such as neonatal thrombocytopenia [88], BPD 
[89], persistent pulmonary hypertension (PPHN), respiratory failure and an increased 
risk for transient tachypnea of the newborn (TTN) [64], as well as cardiovascular 
diseases and intellectual behavioural problems in later life [90]. Since a high number of 
PE pregnancies end in preterm delivery of the fetus, it is often challenging to distinguish 
between the role of prematurity and the effects of PE per se in the above conditions. 
 
DOI:10.14753/SE.2017.2025
21 
 
 
Figure 7. Activation of selected immune cells alters secretion of cytokine profiles that 
contributes to the maternal syndrome of preeclampsia. Initially these adverse events 
cause persistent placental hypoxia followed by inadequate placentation. The 
pathological cytokine profiles may be due to an alteration in immune system regulation, 
or an inadequate fetal allorecognition, or to inflammatory triggers present during 
implantation [69]. 
 
 2.3.3. Early and late activation marker expression in T cells of preterm 
 neonates 
 
 Activation of T lymphocytes is a complex, yet finely regulated cascade of events 
that results in the expression of cytokine receptors, production and secretion of 
cytokines, upregulation of several cell surface molecules, and activation of direct cell 
killing. Therefore, it is one of the cornerstones of the implementation of an appropriate 
immune response for different types of antigens [91].  
Preterm birth affects an estimated number of 15 million infants each year globally [92]. 
The rate of preterm birth ranges from 5% to 18% percent. Premature babies face 
DOI:10.14753/SE.2017.2025
22 
numerous acute and chronic complications, including respiratory, cardiovascular, 
gastrointestinal, and perhaps most importantly, neurodevelopmental problems. Risk 
factors associated with preterm labour include previous preterm births or miscarriages, 
multiple pregnancy, in vitro fertilization, cervical or placental insufficiency, smoking, 
poor nutrition, hypertensive disorders, infections, stress and trauma. Numerous studies 
to date have shown that preterm deliveries associated with preeclampsia (PE), 
premature rupture of membranes (PROM), intrauterine infection and respiratory distress 
syndrome (RDS) are linked with higher levels of neonatal adaptive immune response 
[93]. However, data on T lymphocyte activation markers of preterm infants is scarce 
[94]. 
The most important activation molecules expressed on T lymphocytes can be classified 
as early activation markers, such as CD69 and CD25, and late activation markers, such 
as CD62L and HLA-DR. Additionally, very late activation markers, such as VLA-1 
have also been described, playing a role in lymphocyte adhesion and extravasation [95]. 
  
 CD69 
 
 CD69 is generally regarded as the earliest activation cell surface marker of both 
mononuclear umbilical cord and peripheral blood cells induced by a mitogenic stimulus. 
The expression of CD69 molecule is not restricted to activated lymphocytes, as 
activated neutrophils and eosinophils can also express CD69. Moreover, platelets, 
epidermal Langerhans cells and bone marrow myeloid precursors express CD69 
constitutively. The engagement of CD69 can activate NK and T cells, resulting in 
increased cytotoxic activity and pro-inflammatory cytokine production [96]. CD69 
seems to be expressed in higher levels on the surface of activated neonatal cells when 
compared to adults [97]. Upregulation of CD69 on NK cells was identified as a 
sensitive marker of neonatal infection [98]. 
 
 CD25 
 
 CD25, or the alpha subunit of the IL-2 receptor, is involved in the early stage of 
lymphocyte activation, but it also seems to be critical in maintaining self-tolerance and 
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immune homeostasis. Early work on CD4+ CD25 high+ cells later termed as regulatory 
T cells showed that their activation via their T cell receptor (TCR) generates suppressor 
cells that are capable of non-specifically suppressing the activation of any CD4+ or 
CD8+ T cell [99]. FoxP3+ regulatory T cells, also characterized by high expression of 
CD25 are present at the fetal-maternal interface and have been reported to be important 
for the maternal acceptance of the allogeneic fetus [100]. 
 
 CD62L 
 
 CD62L (L-selectin) is considered a late activation marker and a key regulator of T 
cell trafficking. It acts as a homing receptor for lymphocytes to enter secondary 
lymphoid tissues via high endothelial venules (HEV). Following activation, CD62L is 
rapidly downregulated on T cells, which prevents effector T cells from trafficking to 
lymph nodes through HEV [101]. Activation of CD62L takes place during the first 
postnatal days in preterm infants with RDS, and this activation is associated with the 
development of BPD [102]. Furthermore, it was also demonstrated that carriers of the 
L-selectin 213Ser allele are at increased risk for premature birth and BPD [103]. 
 
 HLA-DR 
 
 HLA-DR molecules are involved in antigen processing and presentation, 
mediating antigen-specific T cell activation [104]. It is known that low levels of HLA-
DR expression on monocytes contributes to impaired neonatal host defence, especially 
in preterm infants [105]. Decreased expression of HLA-DR molecules in preterm 
newborns is linked with development of several complications, such as high incidence 
of bacterial infections and pulmonary morbidity, especially in the presence of RDS 
[106-107]. 
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3.  AIMS 
 
 Our aim was to characterise the inflammatory status of preterm infants at birth 
and during the first week of life and its association with perinatal complications as well 
as the influence of maternal factors. 
 
 The specific aims for our investigations were: 
 
1.  To assess the plasma 25(OH)D concentrations from cord blood of 28 preterm 
infants born before the 30th gestational week and to determine its correlation 
with cellular and soluble indicators of the inflammatory status. Effects of other 
factors, such as gestational age and plasma cortisol levels were also assessed. 
2.  To address the hypothesis that PE impacts the fetal immune system, we analysed 
the prevalence of distinct lymphocyte subsets and plasma cortisol and cytokine 
levels in preterm neonates of PE mothers during the first week of life (at birth 
and on the 1st, 3rd and 7th postnatal days) and compared them to preterm 
neonates with comparable clinical characteristics born from pregnancies not 
complicated by PE. 
3.  To assess the association of gender, gestational and postnatal age, preeclampsia 
(PE), premature rupture of membranes (PROM) and prenatal steroid treatment 
(PS) with the frequency of activated T lymphocyte subsets (CD69+, CD25+, 
CD62L+, HLA-DR) and major T lymphocyte subpopulations (CD4, CD8, Th1, 
Th2, naïve, memory) in peripheral blood during the first postnatal week in 
preterm neonates. Since data on the physiological frequency of these cell subsets 
is challenging to obtain, we aimed to gather preliminary data to describe the 
dynamic postnatal alteration of these parameters in preterm neonates affected by 
different perinatal factors. 
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4. MATERIALS AND METHODS 
 
 Blood samples for all three studies were collected at the Neonatal Intensive Care 
Unit of the 1st Department of Obstetrics and Gynecology, Semmelweis University, 
Budapest, Hungary. Flow cytometry measurements were performed at the Research 
Laboratory of the 1st Department of Pediatrics, Semmelweis University, Budapest, 
Hungary. Some of the patients fulfilling the inclusion criteria for more than one study 
were overlapping across multiple studies. 
 
 
4.1. PATIENTS 
 
 In the study on vitamin D levels, venous cord blood samples were taken from 28 
preterm infants (gestational age: 29 (27-30) weeks, median (range); birth weight: 1080 
(920-1550) grams, median (range)). Patient characteristics are summarized in Table 1. 
All infants had a highly suspected or proven intrauterine infection based on standard 
criteria [108-109]. However, no ongoing inflammatory reaction was detected in patients 
at the time of sampling, as indicated by normal IL-6 levels. Of note, since no suggestive 
clinical signs of chorioamnionitis were present, placental histology was not performed. 
Based on plasma vitamin D levels, patients were divided into two groups (below and 
above median, 23.3 ng/mL), between which all comparisons were made. 
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Table 1. Clinical characteristics of participants in the study on vitamin D levels. Data 
are presented as median (range). * p < 0.05 vs. Above median group. 
 
Clinical characteristics Vitamin D above median 
(n = 14) 
Vitamin D below median 
(n = 14) 
Gestational age (weeks) 28.5 (27-30) 29.5 (29-30) 
Birth weight (grams) 985 (920-1220) 1365 (980-1550) 
Apgar score at 1 min 7 (6-8) 7 (7-8) 
Apgar score at 5 min 9 (9-9) 9 (9-9) 
No. of boys 5 (36%) 5 (36%) 
No. of C-sections 12 (86%) 9 (64%) 
No. of C-sections in labor 4 (29%) 4 (29%) 
No. of steroid prophylaxis 12 (86%) 9 (64%) 
No. of gestational diabetes 1 (7%) 2 (14%) 
No. of preeclampsia 2 (14%) 4 (28%) 
No. of PROM 7 (50%) 7 (50%) 
Duration of PROM (hrs) 18 (3-76) 22 (4-92) 
Plasma cortisol (nmol/L) 873 (301-2488) 575 (244-1078) 
Plasma vitamin D (ng/mL) 27.2 (24.8-38.8) 18.0* (13.7-20.3) 
 
  
 In the study on the effects of preeclampsia, we enrolled 14 preterm neonates born 
to PE mothers and 14 preterm neonates born to healthy mothers as controls. Median 
gestational age was 30 weeks in the PE group and 29 weeks in controls, while 
birthweight was 985 g in the PE group and 1180 g in controls, respectively. All neonates 
had a highly suspected intrauterine infection based on standard criteria [108-109] and 
went through partial septic screen, however, CRP and IL-6 levels were within the 
normal range at birth and on the 1st and 3rd postnatal days. Patient characteristics are 
summarized in Table 2. 
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Table 2. Clinical characteristics of preterm neonates enrolled in the study on the 
effects of PE. Data are expressed as median (range). 
 
Clinical characteristics Preterm without 
Preeclampsia 
Preterm with  
Preeclampsia 
Gestational age (weeks) 29 (24-31) 30 (24-33) 
Birth weight (grams) 1180 (490-1420) 985 (590-1650) 
Apgar score at 1 min 7 (5-8) 7 (4-9) 
Apgar score at 5 min 9 (8-10) 9 (6-10) 
No. of male neonates 4 (29%) 7 (50%) 
No. of neonates born by Cesarean section 9 (64%) 14 (100%) 
No. of neonates with maternal steroid 
prophylaxis 
10 (71%)  12 (86%) 
  
 In the study on activation markers, we enrolled 43 preterm infants. Gestational 
age was 30 (25-33) weeks, while birthweight was 1300 (490-1980) g at birth. The 
suspected ground for preterm birth was PE in 8 cases, PROM in 13 cases, and could not 
be settled in 22 cases. PS treatment was applied in 25 cases. All infants had a highly 
suspected or proven intrauterine infection based on standard criteria [108-109]. PROM 
cases were coupled with elevated IL-6 levels (256.2 (64.8-2358.9) pg/ml) measured in 
cord blood, while IL-6 levels in cord blood of infants who had no PROM were normal 
(11.6 (2.9-45.1) pg/ml). Patient characteristics are summarized in Table 3. 
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Table 3. Clinical characteristics of preterm neonates enrolled in the study on 
activation markers. Data are presented as median (range). 
 
Clinical characteristics Values 
Gestational age (weeks) 30 (25-33) 
No. of infants born before 29th week 13 (30%) 
No. of infants born on 29-30th week 15 (35%) 
No. of infants born after 30th week 15 (35%) 
Birth weight (grams) 1300 (490-1980) 
Apgar score at 1 min 8 (5-9) 
Apgar score at 5 min 9 (7-10) 
No. of male infants 21 (49%) 
No. of neonates born by Cesarean section 26 (60%) 
No. of neonates with maternal steroid prophylaxis 25 (58%) 
No. of neonates with suspected intrauterine infection 43 (100%) 
No. of preeclampsia 8 (19%) 
No. of premature rupture of membranes 13 (30%) 
 
 
4.2. ETHICAL CONSIDERATIONS 
 
 Written informed consent was obtained from parents of subjects, and our study 
was reviewed and approved by an independent ethical committee of the institution 
(Semmelweis University, Budapest). The study was adhered to the tenets of the most 
recent revision of the Declaration of Helsinki. 
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4.3. CBMC ISOLATION 
 
 Cord blood mononuclear cells (CBMCs) were separated by a standard density 
gradient centrifugation (Ficoll Paque, Amersham Biosciences AB, Uppsala, Sweden, 25 
minutes, 400 g, 22 °C) from freshly drawn blood collected in lithium heparin-treated 
tubes (BD Vacutainer, BD Biosciences, San Jose, CA, USA). Peripheral blood samples 
were taken on the 1st, 3rd, and 7th postnatal days of life. Plasma was handled separately 
and frozen until further analysis. 
 
 
4.4. FLOW CYTOMETRY  
 
 CBMCs and peripheral whole blood were stained for 30 min at room temperature 
in the dark with specific monoclonal antibodies.  
 In the study on vitamin D levels we used the following monoclonal antibodies: PE 
Cy7-conjugated CD4, APC-Cy7-conjugated CD8, FITC-conjugated CD25, PerCP-
conjugated CD62L, APC-conjugated CXCR3, PE-conjugated CCR4, APC-conjugated 
CD69, PerCP-conjugated HLA-DR, PerCP-conjugated CD3, APC-conjugated CD161, 
PE-conjugated 6B11, APC-conjugated CD11c, PE-conjugated CD123 and FITC 
conjugated Lin 1 cocktail in separate tubes, respectively (all from BD Biosciences). 
Th1 cells were defined as CD4+ CXCR3+ CCR4-, while Th2 cells were defined as 
CD4+ CXCR3- CCR4+. NK cells were identified as CD3- CD161+, while NKT cells 
were identified as CD3+ CD161+ and invariant NKT (iNKT) cells as CD3+ 6B11+. For 
the determination of DC, pDC and mDC subsets, samples were stained with a lineage 
cocktail containing antibodies against CD3, CD14, CD16, CD19, CD20, and CD56 (Lin 
1). After gating on Lin 1 negative cells, DCS were determined as HLA-DR+, pDCs 
were determined as the CD123+ HLA-DR+ subset, while mDCs were determined as the 
CD11c+ HLA-DR+ subset. 
After washing, cells were analyzed on a BD FACSAria flow cytometer (BD 
Biosciences) equipped with 488 nm and 633 nm excitation lasers. Data were processed 
using the FACSDiVa software. 
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 For the study on the effects of preeclampsia we used the following monoclonal 
anibodies: 
PE Cy7-conjugated CD4, APC-Cy7-conjugated CD8, FITC-conjugated CD25, PerCP-
conjugated CD62L, APC-conjugated CXCR3, PE-conjugated CCR4, APC-conjugated 
CD69, PerCP-conjugated HLA-DR, PerCP-conjugated CD3, APC-conjugated CD161, 
PE-conjugated 6B11, APC-conjugated CD11c, PE-conjugated CD123 and FITC 
conjugated Lin 1 cocktail in separate tubes, respectively (all from BD Biosciences). 
Th1 cells were defined as CD4+ CXCR3+, while Th2 cells were defined as CD4+ 
CCR4+. Naïve T cells were defined as CD4+ CD45RA+, while memory T cells were 
defined as CD4+ CD45RO+. Myeloid dendritic cells (mDCs) were defined as Lin 1- 
CD11c+, while plasmacytoid dendritic cells (pDCs) were defined as Lin 1- CD123+. 
After lysing red blood cells and washing, samples were analyzed on a BD FACSAria 
flow cytometer (BD Biosciences) equipped with 488 nm and 633 nm excitation lasers. 
Data were processed using the FACSDiVa software (BD Biosciences). 
 
 In the study on activation markers we used the following monoclonal antibodies: 
PE-Cy7-conjugated CD4, APC-Cy7-conjugated CD8, FITC-conjugated CD25, PerCP-
conjugated CD62L, APC-conjugated CXCR3, PE-conjugated CCR4, APC-conjugated 
CD69, PerCP-conjugated HLA-DR, FITC-conjugated CD45RA, PE-conjugated 
CD45RO in separate tubes, respectively (all from BD Biosciences).  
Th1 cells were defined as CD4+ CXCR3+, while Th2 cells were defined as CD4+ 
CCR4+. Naïve T cells were defined as CD4+ CD45RA+, while memory T cells were 
defined as CD4+ CD45RO+. 
After lysing red blood cells and washing, CBMCs and PBMCs were analyzed on a BD 
FACSAria flow cytometer (BD Biosciences) equipped with 488 nm and 633 nm 
excitation lasers. Data were processed using the FACSDiVa software. Figure 8. 
demonstrates the gating strategy applied. 
 
4.5. PLASMA CORTISOL AND VITAMIN D LEVELS 
 
 Plasma cortisol levels and vitamin D levels were measured with commercially 
available Roche kits on an Elecsys automated analyzer. 
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4.6. PLASMA CYTOKINE LEVELS 
 
 Cytokine levels were measured using the Bio-Plex Pro Human Cytokine 17-Plex 
Panel (M50-00031YV, Bio-Rad, Hercules, CA, USA) following the manufacturer’s 
instructions. Samples were read using a Bio-Plex reader (Bio-Rad). 
 
 
4.7. STATISTICS 
 
 Data are expressed as median and range. Since Kolmogorov–Smirnoff analysis 
indicated non-normal distribution of data, the Mann-Whitney test was used to make 
comparisons between the study groups in the study on the effects of PE. The sample 
size was estimated to achieve 80% power with 0.45 effect size to detect differences 
between the patient groups.  
The independent effects of gestational and postnatal age, PE, PROM, PS and gender 
were analyzed using the ‘mixed effect model’ method in the study on activation 
markers. This is a statistical model containing both fixed effects and random effects. It 
is particularly used in settings where repeated measurements are made on the same 
statistical units (ie. longitudinal studies), or where measurements are made on clusters 
of related statistical units [110]. 
The mixed effect model was also used to assess the effect of factors other than plasma 
vitamin D levels on the analyzed inflammatory parameters in the study on vitamin D 
levels [111]. These factors were plasma cortisol levels as continuous variables and 
gestational age as categorical variables (27 weeks, 28-29 weeks and 30 weeks). 
Statistics were calculated at 5% significance level (p = 0.05) using the GraphPad Prism 
5 software (La Jolla, CA, USA) and the SAS software (Cary, NC, USA). 
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Figure 8. Gating strategy of flow cytometry measurements in the study on the early 
and late activation markers. Example of a representative sample. FSC – forward 
scatter, SSC – side scatter.  
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5. RESULTS 
 
5.1. THE ROLE OF VITAMIN D LEVELS AT BIRTH IN PRETERM INFANTS 
 
 In the study on vitamin D levels, we included 28 preterm infants with a median 
gestational age of 29 weeks at birth. In the majority of them, vitamin D levels were 
higher than normal in cord blood (23.3 [9.9–45.4] ng/ml (median [range])). Based on 
vitamin D levels, two patient groups were created: below median (<23.3 ng/ml) and 
above median (>23.3 ng/ml) (Table 1.).  
First, we compared the prevalence of pro- and anti-inflammatory cell subsets and 
plasma cytokine levels between these groups. Results are demonstrated in Tables 4. and 
5., respectively. In infants with vitamin D level below median the prevalence of CD4+ 
CXCR3+ (Th1) and CD8+ CXCR3+ cell subsets was higher, while the prevalence of 
CD4+ CCR4+ (Th2), CD8+ CCR4+ and pDC cell subsets was lower than in infants 
with a plasma vitamin D level above median. No difference was detected in the 
prevalence of other cell subsets between the two groups, including lymphocyte 
activation markers (CD25, CD62L, CD69, HLA-DR) and NK cell subtypes. 
Of note, no difference was detected in the plasma cytokine levels investigated as shown 
in Table 5. 
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Table 4. The prevalence of T cell, NK cell and dendritic cell subsets among 
lymphocytes and all PBMCs, respectively, determined by flow cytometry. Data are 
presented as median (range). * p < 0.05 vs. Above median group. 
 
Cell subset Vitamin D  
above median 
Vitamin D  
below median 
CD4+ CXCR3+ (Th1 cells) 4.15 (2.68-5.73) 5.86* (3.85-7.32) 
CD4+ CCR4+ (Th2 cells) 1.56 (1.18-2.01) 1.07* (0.36-1.94) 
CD4+ CD25+ 2.34 (2.00-3.66) 2.45 (0.00-0.06) 
CD4+ CD62L+ 8.69 (7.74-9.86) 9.68 (7.46-10.60) 
CD4+ CD69+ 1.39 (0.87-9.57) 1.68 (1.42-5.15) 
CD4+ HLA-DR+ 5.12 (1.60-17.46) 4.05 (2.16-7.09) 
CD8+ CXCR3+ 8.65 (6.80-9.02) 9.01* (7.39-10.57) 
CD8+ CCR4+ 0.23 (0.09-0.75) 0.12* (0.10-0.23) 
CD8+ CD25+ 1.15 (0.86-2.07) 1.29 (0.15-2.78) 
CD8+ CD62L+ 7.89 (7.04-8.45) 8.05 (6.96-8.54) 
CD8+ CD69+ 3.52 (2.63-6.77) 3.75 (1.06-7.00) 
CD8+ HLA-DR+ 0.51 (0.23-4.02) 0.56 (0.14-0.94) 
CD3- CD161+ (NK cells) 2.94 (0.57-4.31) 1.81 (0.89-2.66) 
CD3+ CD161+ (NKT cells) 1.30 (0.22-1.89) 0.69 (0.34-1.05) 
CD3+ 6B11+ (iNKT cells) 0.02 (0.01-0.06) 0.02 (0.01-0.04) 
Lin 1- HLA-DR+ (DCs) 6.38 (1.89-8.16) 4.34 (1.48-8.40) 
Lin 1- HLA-DR+ CD11c+ (mDC) 0.97 (0.28-2.40) 1.03 (0.12-2.29) 
Lin 1- HLA-DR+ CD123+ (pDC) 1.29 (0.09-2.28) 1.15* (0.64-5.42) 
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Table 5. Cord blood plasma cytokine levels of the investigated preterm infants 
(pg/mL). Data are presented as median (range). 
 
Cytokine Vitamin D above median Vitamin D below median 
MIP 1b 160 (109-247) 201 (146-223) 
MCP1 84 (42-176) 132 (69-182) 
IL-17 55 (30-90) 79 (65-86) 
IL-13 2.45 (0.43-3.45) 1.61 (0.19-2.97) 
IL-12 10.68 (5.22-20.6) 18.85 (9.37-22.39) 
IL-10 3.11 (1.63-6.91) 4 (1.99-7.15) 
IL-8 38 (19-71) 29 (18-58) 
IL-7 0.28 (0.20-1.49) 0.20 (0.20-0.93) 
IL-6 11.38 (4.51-14.53) 7.21 (1.89-16.79) 
IL-5 0.65 (0.43-1.36) 1.08 (0.13-1.75) 
IL-4 0.78 (0.78-0.93) 0.78 (0.78-1.66) 
IL-2 1.07 (0.07-2.30) 1.84 (0.07-2.62) 
IL-1b 2.82 (0.46-3.56) 1.47 (0.22-4.04) 
IFN-g 44.85 (14.85-79.43) 133.1 (47.14-225.1) 
GM-CSF 136.22 (11.38-198.23) 201.6 (21.54-243.9) 
G-CSF 11.13 (2.40-20.90) 8.00 (1.80-30.61) 
TNF-a 19.22 (0.95-33.1) 19.22 (0.30-65.23) 
 
 Since the inflammatory status might also be influenced by gestational age and 
plasma cortisol levels, we used the mixed effect model to assess the effects of these 
factors. According to our analysis, CD4+ CXCR3+ (Th1) lymphocytes were also 
influenced by both gestational age (at the gestational age of 28–29 weeks) and plasma 
cortisol levels, while CD8+ CXCR3+ and CD8+ CCR4+ lymphocytes were affected by 
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gestational age only (in the 28–29 weeks and ≥30 weeks categories, respectively). 
Results are shown in Table 6. and Figure 9. Plasmacytoid dendritic cells (pDCs) and 
CD4+ CCR4+ (Th2) lymphocytes are the only cell subsets from the current study which 
were only influenced by vitamin D levels. 
 
Table 6. Positive results of mixed effect model analysis for gestational age and plasma 
cortisol levels. Estimate and % change values demonstrate the difference of the given 
parameter related to presence of the investigated effect. 
 
Cell subset Effect Effect group p Estimate value % change 
CD4+ CXCR3+ Gestational age 28-29 weeks 0.0267 1.2030 232 
Cortisol level  0.0052 0.3625 43 
CD8+ CCR4+ Gestational age 30 weeks 0.0492 -2.1341 -11 
CD8+ CXCR3+ Gestational age 28-29 weeks 0.0379 0.6619 93 
Gestational age 30 weeks 0.0397 0.5395 69 
 
 
Figure 9. Diagram of positive results of mixed effect model analysis for gestational 
age and plasma cortisol levels and vitamin D results. 
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5.2. THE IMPACT OF PREECLAMPSIA IN PRETERM NEONATES 
 
 In the study on the effects of PE, we first compared the prevalence of distinct 
lymphocyte, NK and dendritic cell subsets between the two groups. Results are 
summarized in Table 7. 
The prevalence of CD4+ T lymphocytes and CD4+HLA-DR+ T cells was significantly 
lower in preterm neonates of PE mothers on postnatal day 3 (p= 0.0159 and p= 0.0348, 
respectively) when compared with preterm neonates born to non-PE mothers. In 
contrast, memory T cells (CD4+CD45RO+) were found to have a significantly higher 
prevalence in PE on day 7 (p= 0.0308) when compared with the control group. 
The prevalence of CD8+CXCR3+ cells was significantly lower in PE on postnatal days 
1 and 7 (p= 0.0009 and p= 0.0163, respectively) when compared with control subjects. 
CD8+CD69+ T lymphocytes had a lower prevalence on days 0 and 1 (p= 0.0109 and p= 
0.0015, respectively) in preterm neonates born to PE mothers. Furthermore, CD8+HLA-
DR+ T cells had a significantly lower prevalence in PE on days 0, 3 and 7 (p= 0.0084, 
p= 0.0308 and p= 0.0019, respectively). mDCs had a lower prevalence on days 1 and 3 
(p= 0.0011 and p= 0.0538, respectively) in PE neonates when compared with controls. 
No significant difference was detected in the prevalence of other investigated cell 
subsets between the two groups, including CD3+ T cells, cytotoxic T cells, naïve T 
cells, CD25+ and CD62L+ activated T cells, Th1 and Th2 cells, NKT, iNKT, NK cells 
or pDCs. 
We also compared plasma cytokine levels between the two groups. Results are shown in 
Table 8. Interestingly, the indicated cytokine levels are significantly higher in preterm 
neonates of PE mothers on days 1, 3 and 7 and significantly lower on day 0 when 
compared to the control group. Of note, monocyte chemotactic protein-1 (MCP-1) and 
IL-4 had significantly higher levels on all 3 days (1, 3 and 7) (MCP-1: p= 0.0069, p= 
0.0089 and p= 0.0178, respectively; IL-4: p= 0.0013, p= 0.0339 and p= 0.0106, 
respectively) in preterm neonates of PE mothers. Cortisol levels were found to be 
significantly lower in PE neonates on day 1 and 7 (p= 0.0370 and p= 0.0471, 
respectively). 
 
DOI:10.14753/SE.2017.2025
38 
Table 7. Significant results of cell prevalence data of the enrolled preterm neonates in 
the study on the effects of PE, determined by flow cytometry. Data are given as median 
and (range). * represents significant values, p≤ 0.05. 
 
Cell subset Day Preterm without 
Preeclampsia 
Preterm with  
Preeclampsia 
p value 
 
CD4+ in all cells 
0 20.76 (1.57-54.43) 12.59 (0.17-36.72) 0.1322 
1 7.95 (0.44-24.63) 3.53 (0.0-15.76) 0.1029 
3 10.42 (0.92-32.96) 1.5 (0.01-21.21) 0.0159* 
7 10.77 (0.87-58.36) 1.72 (0.07-40.23) 0.1129 
 
CD4+HLA-DR+ 
in CD4+ cells 
0 13.47 (5.17-74.75) 7.42 (0.0-24.18) 0.1063 
1 7.02 (1.91-69.60) 6.13 (0.63-19.96) 0.2413 
3 7.66 (2.61-17.98) 2.73 (0.97-15.27) 0.0348* 
7 7.58 (0.66-15.22) 7.02 (0.43-28.82) 0.9085 
 
CD4+CD45RO+ 
in CD4+ cells 
0 0.91 (0.13-19.15) 1.76 (0.21-3.30) 0.4599 
1 0.31 (0.09-2.92) 0.51 (0.0-27.78) 0.2233 
3 0.28 (0.01-3.84) 0.42 (0.0-7.41) 0.8903 
7 0.6 (0.08-3.84) 1.2 (0.12-6.04) 0.0308* 
 
CD8+CXCR3+ in 
CD8+ cells 
0 83.46 (45.21-97.79) 85.08 (10.67-97.01) 0.9346 
1 91.82 (80.88-98.08) 74.23 (50-93.79) 0.0009* 
3 90.41 (0.0-98.39) 88.40 (16.30-100) 0.8005 
7 94.13 (82.1-97.34) 88.45 (0.0-98.84) 0.0163 
 
CD8+CD69+ in 
CD8+ cells 
0 82.16 (3.39-96.13) 30.1 (0.0-92.42) 0.0109* 
1 72.33 (14.23-93.53) 31.22 (0.0-91.56) 0.0015* 
3 68.13 (0.0-93.25) 19.14 (0.0-83.53) 0.1235 
7 70.42 (0.13-91.96) 26.52 (0.0-91.68) 0.4484 
DOI:10.14753/SE.2017.2025
39 
 
CD8+HLA-DR+ 
in CD8+ cells 
0 1.51 (0.43-2.67) 0.61 (0.0-1.83) 0.0084* 
1 0.80 (0.12-55.51) 0.52 (0.0-26.32) 0.3702 
3 0.79 (0.38-5.01) 0.32 (0.0-3.04) 0.0308* 
7 1.3 (0.2-2.99) 0.27 (0.0-1.07) 0.0019* 
 
Lin 1- CD11c+ in 
Lin 1- cells 
0 46 (3.90-83.54) 19.06 (5.84-65.22) 0.1514 
1 26.84 (3.06-91.42) 10.89 (0.79-44.20) 0.0538* 
3 44.42 (0.0-75.39) 11.4 (0.38-39.65) 0.0011* 
7 37.42 (5.61-75.84) 19.39 (0.62-65.98) 0.2541 
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Table 8. Significant results of plasma cytokine and cortisol levels of the enrolled 
preterm neonates in the study on the effects of PE (pg/mL). Data are given as median 
and (range). All p values are significant (p≤ 0.05). 
 
Cytokine Day Preterm without 
Preeclampsia 
Preterm with  
Preeclampsia 
p value 
MIP-1b 7 118.2 (66.96-183) 1385 (43.41-7579) 0.0106 
MCP-1 1 67.05 (12.69-319.5) 267.9 (85.07-2896) 0.0069 
MCP-1 3 53.91 (17.18-294.7) 286.4 (17.36-1864) 0.0089 
MCP-1 7 81.82 (13.68-200.8) 182.2 (15.10-925.6) 0.0178 
IL-17 7 32.85 (10.32-83.83) 104.3 (4.72-4345) 0.0185 
IL-13 0 3.78 (0.5-8.290) 1.09 (0.11-5) 0.0131 
IL-8 7 22.16 (5.92-79.46) 1475 (1.84-58080) 0.0141 
IL-6 7 8.28 (1.99-16.15) 111.9 (3.04-237.1) 0.0035 
IL-4 1 0.78 (0.02-1.93) 6.22 (0.78-17.5) 0.0013 
IL-4 3 0.78 (0.14-1.38) 1.93 (0.02-4.67) 0.0339 
IL-4 7 0.78 (0.02-1.38) 2.45 (0.03-12.9) 0.0106 
IL-2 1 0.07 (0.07-1.84) 1.84 (0.07-15.72) 0.0199 
IL-2 7 0.07 (0.07-1.84) 2.46 (0.07-15.32) 0.0131 
IFN-g 0 157.8 (7.24-775) 22.18 (1.11-133.1) 0.0100 
TNF-a 0 68.86 (2.07-334) 15.29 (0.54-61.61) 0.0115 
Cortisol 1 845.3 (161.7-2458) 186.1 (41.92-1144) 0.0370 
Cortisol 7 381.9 (146.9-792.8) 222.2 (137.3-573.5) 0.0471 
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5.3. EARLY AND LATE ACTIVATION MARKER EXPRESSION IN T CELLS 
OF PRETERM NEONATES 
 
 The frequency of CD4+ CD25+ and CD8+ CD25+ activated T lymphocytes was 
higher in case with PROM at all time points. We observed a decrease in the frequency 
of CD4+ and CD8+ T lymphocytes as well as the CD4+/CD8+ T cell ratio in PE 
compared to infants not affected by PE at all time points. The frequency of 
CD4+CD62L+ and CD8+ CD62L+ T lymphocytes was higher in male infants when 
compared to female infants at all time points. None of the investigated factors had an 
effect on the expression of the HLA-DR and CD69 activation markers,or the frequency 
of Th1 (CD4+ CXCR3+), Th2 (CD4+ CCR4+), naïve (CD45RA+) and memory 
(CD45RO+) T cell subsets. The frequency of Th1 (CD4+ CXCR3+) lymphocytes was 
higher in infants born before the 29th gestational week compared to those born on the 
29-30th gestational week on postnatal days 1 and 3. When we looked at the effect of 
postnatal age (day 1, 3 and 7 of life) on the frequency of the investigated markers and 
subsets, we detected several changes. CD4+ T cells have a higher frequency on 
postnatal days 0 and 3 when compared to day 7. CD4+ CD25+ cells had a lower 
frequency on postnatal day 0 than on day 7. Of note, Th2 (CD4+ CCR4+) lymphocytes 
also had a lower frequency on postnatal days 1 and 3 when compared to day 7. Results 
are summarized in Table 9. and Figure 10. 
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Table 9. Significant results of mixed effect model analysis for the investigated factors 
in the study on activation markers. “% change” is expressed vs. Day 7 for postnatal 
age, vs. PE (present) for preeclampsia, vs. PROM (present) for premature rupture of 
membranes, vs. Boys for gender, vs. < 29 weeks for gestational age. 
 
T cell subset Effect p Estimate % change 
CD4+ Day 0 0.0487 0.04143 4 
Day 3 0.0018 0.06641 6 
No PE 0.023 0.09089 9 
CD8+ No PE 0.0371 0.02683 2 
CD4+ CD25+ Day 0 0.0331 -0.1305 -87 
No PROM 0.0219 -0.1826 -83 
CD8+ CD25+ No PROM 0.0285 -0.1592 -86 
CD4+ CD62L+ Boys 0.0572 0.1071 10 
CD8+ CD62L+ Boys 0.0309 0.1404 15 
CD4+ CXCR3+ 29-30 weeks 0.0291 -0.1256 -88 
CD4+ CCR4+ Day 1 0.0341 -0.1342 -87 
Day 3 0.024 -0.1431 -86 
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Figure 10. Box-plots representing frequency values of the investigated cell subsets in 
different subgroups of preterm infants at birth (Day 0) and on days 1, 3 and 7 of life 
in the study on activation markers. Horizontal line: median, box: interquartile range, 
whisker: range. PE – preeclampsia, PROM – premature rupture of membranes. * p < 
0.05 vs. No PROM, ** p < 0.05 vs. Male infants, *** p < 0.05 vs. No PE, # p < 0.05 vs. 
Day 0, ## p < 0.05 vs. Day 0. 
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6. DISCUSSION 
 
6.1. PLASMA VITAMIN D LEVELS CONTROL THE INFLAMMATORY 
BALANCE IN PRETERM INFANTS 
 
 Vitamin D can modulate both the innate and adaptive immune responses. 
Deficiency in vitamin D is associated with increased autoimmunity and susceptibility to 
infection. Antigen presenting cells (macrophages and dendritic cells), T cells and B cells 
have the necessary machinery to synthesize and respond to vitamin D [112]. Stimulation 
of T cells with vitamin D impairs their proliferation and pro-inflammatory cytokine 
secretion (IFN-g, IL-17) and promotes the development of Th2 and Treg cells [113]. It 
was also found that vitamin D inhibits the ability of pDCs to induce T cell activation in 
mouse and man [114]. 
pDCs are important players within the immune system, and are the main producers of 
type I IFN upon TLR9 activation, thus linking the innate and adaptive immune 
responses. In our study, the prevalence of pDCs was solely influenced by vitamin D 
levels: infants with a vitamin D level below median had a lower prevalence of pDCs. 
Increased susceptibility to viral infections in preterm neonates might be associated with 
altered pDC function. Recent studies found similar numbers of circulating pDCs in term 
and preterm newborns and healthy adults. The pDC population seems to appear early in 
fetal circulation, below 27 weeks. However, pDCs from preterm newborns demonstrate 
an impaired antiviral cytokine response, in terms of hampered IFN-a production, and 
also show distinct immature morphological features, such as the lack of TLR9 
functionality, leaving preterm newborns vulnerable to viral infections [114]. The other 
cell subset we found to be influenced by vitamin D levels only in the current study are 
Th2 cells. The prevalence of this cell subset was also found to be lower in infants with a 
vitamin D level below median. This positive correlation between plasma vitamin D 
levels and Th2 cell prevalence is in line with earlier results [113]. Neonatal T cells 
appear to have a strong bias towards Th2 polarization in vitro [115-116]. Subsequent 
reports indicated that the skewing to Th2 responses seen in vitro may accurately reflect 
the activities of neonatal T cells in vivo. For instance, exposure of human fetal T 
lymphocytes to common allergens, such as HDM or OVA, which commonly cross the 
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placenta induce their differentiation into Th2 cells. This Th2 response, comprising IL-4, 
IL-5, IL-6, IL-9 and IL-13, was found in all newborn infants and seemed to be 
dominated by high production of IL-10. In later life, normal immune deviation 
mechanisms redirect these fetal immune responses toward the Th1 cytokine phenotype 
in non-atopic adult individuals, indicating that the key etiologic factor in atopic disease 
may not be the initial acquisition of allergen-specific Th2-skewed immunity per se 
[117]. Besides the influence of vitamin D levels on Th1 and cytotoxic T cell subsets 
(CD8+ CXCR3+ and CD8+ CCR4+), our study identified that the prevalence of Th1 
lymphocytes were also influenced by both gestational age and plasma cortisol levels, 
while cytotoxic T cells were further influenced by gestational age only. Glucosteroids 
have a role in inhibiting the IFN-g response in adults, acting directly on T cells or 
indirectly through IL-12. In this way, an increase in plasma cortisol would induce a 
decrease in the Th1 products with the imbalance between Th1/Th2 cytokines and a shift 
to Th2 response [118]. Pinto et al. found an association between increased plasma 
cortisol levels and a decreased Th1-type response in infants between 6 and 12 months of 
age with severe RSV (Respiratory Syncytial Virus) infection [119]. On the contrary, our 
findings indicate that the prevalence of Th1 cells in cord blood of preterm neonates 
increases with higher plasma cortisol levels. This contradiction might be explained by 
altered glucosteroid homeostasis and effects in preterm infants. Cortisol is an important 
physiologic hormone for stress in preterm neonates. Neonates under stress have been 
shown to have impaired production of cortisol and accumulation of precursors for 
cortisol [120]. The source of fetal cortisol is also limited because the adrenal cortex 
does not produce cortisol de novo from cholesterol until around the gestational age of 
30 weeks. Although the fetus may produce cortisol earlier in gestation using placental 
progesterone as a precursor, the preterm delivery will leave the infant with a paucity of 
the enzymes required for de novo cortisol synthesis [120-121]. CD8+ cytotoxic T cells 
express relatively high levels of VDR (20). Our current study confirms that vitamin D 
has an important effect on the prevalence of cytotoxic T cell subsets in preterm infants. 
Interestingly, our results show that the prevalence of the CD8+CXCR3+ cell subset was 
higher, while that of CD8+ CCR4+ cells was lower in the group of infants with a serum 
vitamin D level below median. The same pattern was observed concerning the 
prevalence of CD4+ cells expressing these chemokine receptors, which might indicate 
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that vitamin D may have a direct effect on their cellular expression.  
 
 
6.2. MATERNAL PREECLAMPSIA HAS A MAJOR IMPACT ON THE 
IMMUNE SYSTEM OF PRETERM INFANTS 
 
 PE is one of the most common complications of pregnancy and it is associated 
with adverse health outcomes for the mother and her offspring. Dynamic changes are 
anticipated in the immune system of preterm neonates of PE mothers immediately after 
birth. 
The prevalence of CD4+ T cells was significantly lower on day 3 in neonates of PE 
mothers when compared with control subjects and a similar trend was observed on the 
other days. These findings are in line with previous results of Kotiranta-Ainamo et al., 
showing that neonates born to PE mothers had significantly less CD4+ cells and 
CD4+CD8+ double-positive cells compared to neonates not affected by PE. 
Furthermore, their study also identified a decrease in the CD4/CD8 ratio in PE neonates 
[93]. 
The available data on the expression of HLA-DR+ T cells in preterm neonates born to 
PE mothers is sparse. HLA-DR molecules are involved in antigen processing and 
presentation, mediating antigen-specific T cell activation [94]. Our study identified a 
significantly lower prevalence of CD4+HLA-DR+ T lymphocytes in preterm neonates 
of PE mothers on postnatal day 3 when compared with preterm neonates born to healthy 
mothers. Furthermore, CD8+HLA-DR+ T cells also had a significantly lower 
prevalence in PE on days 0, 3 and 7, when compared to control subjects. Previously, it 
was demonstrated that low levels of HLA-DR expression in preterm newborns is linked 
with the development of several complications, including high incidence of bacterial 
infections and pulmonary morbidity, especially in the presence of respiratory distress 
syndrome (RDS) [106-107]. Several research groups have reported low HLA-DR 
expression on monocytes on the first days of life (1 and 3) in preterm neonates (<32 
weeks) and in very low birth weight (VLBW) neonates. These results seemed to be 
associated with impaired neonatal host defense, also contributing to the high incidence 
of bacterial infections, sepsis and subsequent development of BPD [105-107]. CD69 is 
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generally regarded as the earliest cell surface activation marker of both umbilical cord 
and peripheral blood mononuclear cells induced by a mitogenic stimulus. The 
engagement of CD69 can activate NK and T cells, resulting in increased cytotoxic 
activity and pro-inflammatory cytokine production [97]. Luciano et al. showed that cord 
blood T cells from babies born from preterm labour or chorioamnionitis are 
characterized by increased expression of CD69+ T cells [94]. Our observations show 
that CD8+CD69+ T lymphocytes have a significantly lower prevalence on days 0 and 1 
in preterm neonates born to PE mothers. These differences observed in the expression of 
activation markers may reflect that T cell activation kinetics is altered in neonates 
affected by PE with a more chronic activation phenotype, and a down-regulation of 
early activation markers. 
Since neonates have limited antigen exposure, we expected to find low numbers of 
memory T cells. In contrast, memory T cells (CD4+CD45RO+) were found to have a 
significantly higher prevalence in PE on day 7 when compared with the control group. 
This result suggests a preconditioning of the neonatal immune system in PE potentially 
through increased antigen exposure or inflammatory influence via the placenta. These 
findings are also in line with previous results, where the percentage of CD4+CD45RO+ 
and CD8+CD45RO+ memory T cells was higher in neonates born to PE mothers when 
compared to full-term newborns of healthy women. These key findings reflect a 
longstanding immune activation in PE thought not to occur during normal fetal 
development [122]. 
An important feature of systemic inflammation in PE is the predominance of Th1-type 
immunity [74-77]. Indeed, inflammatory cytokine levels (IL-2, IL-6, IL-8, IL-17, MIP-
1b, MCP-1) were higher from postnatal day 1 onwards in the PE group. CXCR3 
expression is associated with inflammatory cytokine production in CD4+ and CD8+ 
cells [123]. Interestingly, and in contrast to the above, the prevalence of CD8+CXCR3+ 
cells was significantly lower in PE neonates on postnatal days 1 and 7 when compared 
with control subjects.  
Dendritic cells develop as an arm of the innate resistance to pathogens after birth, but 
are also competent partners for antigen presentation and the stimulation of the T cell 
adaptive immunity in early life [124]. mDCs capture antigens in the periphery and 
initiate adaptive immune responses and they are also critical producers of IL-12 in 
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response to bacterial stimuli [125]. We report that CD11c+ mDCs had a significantly 
lower prevalence on days 1 and 3 in PE neonates when compared with neonates of 
uncomplicated pregnancy. This feature might be due to a negative feedback mechanism 
playing a role in decreasing antigen presenting cell (APC) prevalence due to increased 
basal stimulation of T cells. Further studies are needed to confirm this hypothesis. 
Cytokines play pivotal roles not only in signalling within the immune system, but also 
in reproductive regulatory mechanisms, such as ovulation, implantation, placentation 
and parturition [126]. In the current study, among the plasma cytokines tested, MCP-1 
had significantly higher levels on all 3 postnatal days in preterm neonates of PE 
mothers. MCP-1 is a chemokine secreted by different cell types and its increased 
expression plays an important role in the pathogenesis of various diseases, such as 
diabetes, nephropathies, allergies and inflammatory bowel disease [127]. MCP-1 is also 
important for the development of the placenta and thus, maintaining a normal pregnancy 
[128]. Therefore, high levels of this cytokine crossing the placenta might be part of a 
compensatory mechanism for the decreased level of placentation and placental function 
observed in PE. Furthermore, high levels of MCP-1 in cord blood of preterm neonates 
was closely related to the prevalence of neonatal RDS, chronic lung disease and 
gestational age [129].  
Interestingly, most cytokine levels were higher on postnatal days, but lower at birth in 
neonates born to PE mothers. This finding raises the notion that the regulation of the 
inflammatory response at parturition might be differently regulated in PE compared to 
healthy pregnancy. Currently, no earlier data are available to confirm this hypothesis. 
Further studies are warranted to investigate this phenomenon and its role in the 
development of neonatal immune-mediated complications. 
Cortisol levels were found to be significantly lower in PE neonates on day 1 and 7, 
respectively. The fetus is in chronic stress in PE due to placental insufficiency with 
elevated cortisol levels, contributing to surfactant production, lung maturation, and the 
clinical observation that RDS is less common in preterm neonates of PE mothers [130]. 
Therefore, the acute cortisol response during the first postnatal week evoked by birth 
and perinatal transition might be suppressed in the presence of PE due to preceding 
chronic cortisol exposure. 
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6.3. EARLY AND LATE T LYMPHOCYTE ACTIVATION MARKERS ARE 
ASSOCIATED WITH PERINATAL COMPLICATIONS IN PRETERM 
INFANTS 
 
 Both prenatal and postnatal inflammation are important factors in the 
pathogenesis of many adverse outcomes in preterm infants. An important feature of the 
inflammatory response is T lymphocyte activation and the expression of early and late 
activation markers on T cells. Luciano et al. demonstrated that preterm deliveries are 
associated with higher levels of T cell activation markers, such as CD25, HLA-DR, and 
CD69 compared to term deliveries. In their study, clinical chorioamnionitis was also 
associated with an increase in T cell activation markers. Their findings support that fetal 
adaptive immune activation in utero is closely associated with preterm labor [94]. Our 
study shows that the frequency of CD4+ CD25+ and CD8+ CD25+ activated T 
lymphocytes is higher in cases with PROM. Similarly to other obstetrical pathologies, 
the etiology of PROM is multifactorial. However, there is evidence suggesting that 
subclinical intrauterine infection is a major factor in the pathogenesis of PROM [131]. 
The pathogens ascending into the decidua and entering the fetal membranes generate a 
cascade of maternal and fetal inflammatory responses that finally result in membrane 
weakening and rupture [132]. In our patient population, PROM was also associated with 
an elevation of cord blood IL-6 levels, indicating ongoing inflammation probably due to 
intrauterine infection in these infants. The increased expression of CD25 on neonatal T 
lymphocytes might be another representation of this inflammatory response. PE is a 
major cause of fetal and maternal morbidity and mortality and is recognized as a 
multisystem disorder of human pregnancy. Although maternal immunological 
alterations, such as an increase in the Th17/Treg ratio [80], are relatively well described 
in PE, very limited information is available on how this disorder affects the 
fetal/neonatal immune system. In our current study, we observed a decrease in the 
frequency of CD4+ and CD8+ T lymphocytes as well as the CD4+/CD8+ T cell ratio in 
PE compared to infants not affected by PE. These findings are in line with previous 
results [93]. However, no clear cause of this phenomenon has been identified. 
Theoretically, intrauterine malnutrition that often affects fetuses in PE pregnancies, may 
be a factor delaying or inhibiting maturation if immune cell types. The frequency of 
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CD62L+ or L-selectin expressing T lymphocytes was higher in male infants when 
compared to female neonates in our study. Previous investigations demonstrated that the 
altered expression and polymorphisms of selectins are related to prematurity and BPD 
[103]. Male vulnerability has been previously noted in infants. Males had more 
postnatal complications compared to females, including lower Apgar scores, higher 
supplemental oxygen need, higher rates of RDS, a poor neurological outcome at follow-
up, and a higher overall perinatal mortality [133]. It has also been suggested that lung 
immaturity in premature boys contributes to their poorer outcome [134]. Thus our 
results might indicate that the elevated morbidity of male infants is closely linked to a 
higher frequency of CD62L+ lymphocytes. This is also in line with findings of Turunen 
et al. who demonstrated that RDS is associated with a lower T cell count and a higher 
frequency of CD62L expressing cells. The authors concluded that increased frequency 
of activated T cells predicts the development of BPD, and systemic T cell activation 
could mediate inflammation contributing to its pathogenesis [102]. 
Prenatal steroids undisputedly decrease neonatal morbidity and mortality by improving 
fetal lung maturation. The thymus is essential for the development and selection of T 
cells, and thymocytes are very sensitive to steroids [135]. In the current study, PS 
treatment did not affect the frequency of lymphocyte activation markers during the first 
postnatal week of life. Thus, based on our results, PS does not exert an 
immunomodulatory effect on the frequency of activated lymphocytes investigated in 
this study. Maturation of the adaptive immune responses occurs mostly after birth. 
Activated CD25+ CD4+ T cells had a lower frequency at birth when compared to day 7 
of life, probably due to the lack of antigenic stimulation from the environment in utero. 
Further studies are needed to elucidate the effects of the transition occurring after birth. 
Th2 lymphocytes appeared to have a lower frequency on postnatal days 1 and 3 when 
compared to day 7. Cytokine responses are skewed towards the Th2 direction in the 
fetus. This bias is thought to contribute to the prevention of fetal rejection by the 
maternal immune system [6]. Preterm and term neonates are thought to be vulnerable to 
infection due to this bias to a Th2 phenotype [136]. However, parturition, independently 
of the presence of infection, is associated with a marked Th1 response. This might be 
represented by lower Th2 cell numbers directly after birth in preterm infants on days 1 
and 3 of life. 
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6.4. LIMITATIONS 
 
 Limitations of our studies include small sample sizes due to clinical 
considerations regarding sampling. We also lack correlation with maternal serum 
vitamin D levels, as well as data on maternal vitamin D supplementation during 
pregnancy in the vitamin D study. 
Larger sample sizes in future studies will allow more detailed subgroup analysis based 
on gestational age and neonatal complications (such as infections).  
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7. CONCLUSIONS 
 
1. Low plasma vitamin D levels are associated with higher Th1, lower Th2 and 
lower pDC peripheral cell prevalences in the preterm infant. 
 
2. pDCs and Th2 lymphocytes are the only cell subsets which were solely 
influenced by vitamin D levels, but not by plasma cortisol levels or gestational 
age. 
 
3. The prevalence of CD4+ T lymphocytes and CD4+HLA-DR+ T cells was 
significantly lower in preterm neonates of PE mothers on postnatal day 3 when 
compared with preterm neonates born to non-PE mothers. 
 
4. Memory T cells (CD4+CD45RO+) were found to have a significantly higher 
prevalence in PE infants on day 7. 
 
5. Investigated cytokine levels are significantly higher in preterm neonates of PE 
mothers on days 1, 3 and 7 and significantly lower on day 0 when compared to 
the control group. 
 
6. Cortisol levels were found to be significantly lower in PE neonates on day 1 and 
7 of life. 
 
7.  Higher expression of CD25+ T lymphocytes is associated with PROM. 
 
8. The expression of CD62L+ T lymphocytes was higher in male compared with 
female infants. 
 
9. Antenatal steroid prophylaxis did not affect the frequency of the investigated 
markers. 
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8. SUMMARY 
 
 The hallmark of the immune system is that it recognizes invading foreign 
organisms, prevents their spread, and ultimately clears them from the body. It also plays 
an important role in the regulation of the inflammatory response often related to 
complications affecting preterm infants. The preterm immune system is not fully 
developed compared to a term neonate or an adult individual, and seems to be 
compromised leading to different long term complications due to perinatal and postnatal 
factors and events. 
 
 Our aim was to characterise the inflammatory status of preterm infants at birth 
and during the first week of life and its association with perinatal complications as well 
as the influence of maternal factors. 
We assessed the prevalence of distinct immune cell subsets in cord and peripheral blood 
samples collected from different groups of preterm infants using flow cytometry. We 
also measured plasma cortisol, vitamin D and cytokine levels with immunoassays, and 
collected relevant clinical data from study participants. 
We correlated plasma 25(OH)D concentrations in cord blood of preterm infants born 
before the 30th gestational week with different immune cell subpopulations, cytokine 
and cortisol levels as well as with gestational age. Our results showed that low vitamin 
D levels are associated with higher Th1 and lower Th2 and pDC prevalences. These 
data suggest that vitamin D has a major role in controlling the inflammatory status of 
preterm infants. 
In order to determine how PE impacts the fetal immune system, we assessed the 
prevalence of distinct lymphocyte subsets and plasma cortisol and cytokine levels in 
peripheral blood samples of preterm neonates of PE mothers during their first week of 
life and compared them to preterm neonates with comparable clinical characteristics 
born from pregnancies not complicated by PE.  
The prevalence of CD4+ cells was lower in PE infants while that of memory T cells was 
higher. Myeloid DCs had a lower prevalence in PE neonates. Interestingly, the indicated 
cytokine levels are significantly higher in preterm neonates of PE mothers on days 1, 3 
and 7 and significantly lower on day 0 when compared to the control group. Cortisol 
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levels were found to be significantly lower in PE neonates on day 1 and 7 of life. 
We also described the association of distinct perinatal events and factors, such as 
gestational age, PE, PROM, PS and gender with the frequency of activated T 
lymphocyte subsets and major T lymphocyte subpopulations in cord blood and 
peripheral blood during the first week of life in preterm neonates. The frequency of 
CD25+ T lymphocytes was higher in PROM. The frequency of CD4+ and CD8+ cells 
and the CD4+/CD8+ cell ratio was decreased in PE. The frequency of CD62L+ T 
lymphocytes was higher in male compared with female infants. PS did not affect the 
frequency of the investigated markers. CD4+ CD25+ cells had a lower frequency at 
birth than on day 7. Th2 lymphocytes had a lower frequency on postnatal days 1 and 3 
when compared to day 7. 
  
 The current studies bring new insight into the association between the immune 
system of preterm infants and perinatal complications which might help to elaborate 
diagnostic and therapeutic methods that could be beneficial in improving outcome of 
this vulnerable population. 
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9. ÖSSZEFOGLALÁS 
 
 Az immunrendszer fő feladata a kórokozók felismerése, a szervezetben való 
terjedésük megakadályozása, valamint végleges eltávolítása. Fontos szerepet játszik 
azonban a gyulladásos folyamatok szabályozásában is, melyek gyakran társulnak a 
koraszülötteket érintő szövődményekhez. A koraszülöttek immunrendszere fejletlenebb 
a felnőttek, vagy akár az érett újszülöttek immunrendszeréhez képest, és eltérő 
működése hosszú távú szövődmények kialakulásához vezethet különböző peri- és 
postnatális és tényezők, történések következményeként. 
 
 Vizsgálataink során célunk volt, hogy jellemezzük a koraszülöttek gyulladásos 
státuszát megszületéskor és az első élethéten, és ennek összefüggéseit a perinatális 
szövődményekkel, valamint különböző anyai hatásokkal. 
Koraszülöttek különböző csoportjaitól gyűjtöttünk köldökzsinórvér- és perifériás 
vérmintákat, melyekben áramlási citometria segtségével vizsgáltuk az egyes immun 
sejttípusok prevalenciáját. Immunoassay módszerrel mértük a plazmában a kortizol, D-
vitamin és különböző citokinek szintjeit, valamint méréseinket összevetettük a releváns 
klinikai adatokkal. 
Vizsgáltuk a köldökzsinórvér 25(OH)D-vitamin szintjének összefüggéseit a fenti 
paraméterekkel 30 gesztációs hét előtt született koraszülöttek esetén. Eredményeink 
alapján az alacsony D-vitamin szint összefüggésbe hozható a Th1 sejtek magasabb, 
valamint a Th2 és pDC sejtek alacsonyabb arányával. Ezen eredmények arra utalnak, 
hogy a D vitamin fontos szerepet játszik a gyulladásos állapot szabályozásában 
koraszülöttek esetén. 
Annak megállapítására, hogy az anyai preeclampsia (PE) hogyan befolyásolja a magzati 
immunrendszert, vizsgáltuk a különböző limfocita altípusok prevalenciáját és a plazma 
koritzol- és citokinszintjeit PE-s várandósságból született koraszülöttek első élethéten 
vett perifériás vérmintáiban PE-val nem szövődött, hasonló klinikai jellemzőkkel bíró 
koraszülöttekhez hasonlítva. A CD4+ sejtek prevalenciája alacsonyabb, míg a memória 
T sejteké magasabb volt a PE-s esetekben. A myeloid dendritikus sejtek aránya szintén 
alacsonyabb volt a nem PE-s esetekhez viszonyítva. Érdekes módon a vizsgált citokinek 
plazmaszintjei magasabbak voltak az 1., 3. és 7. életnapokon PE-ban, alacsonyabbak 
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azonban közvetlenül megszületés után. A kortizolszintek alacsonyabbak voltak az 1. és 
a 7. életnapokon a PE-s csoportban. 
Vizsgáltuk továbbá különböző perinatális tényezők és események, mint a gesztációs kor, 
PE, PROM, prenatális szteroidkezelés, vagy a magzati nem összefüggéseit az aktivált T 
sejtek és egyéb nagy T sejt altípusok gyakoriságával köldökzsinórvérben és az első 
élethéten vett perifériás vérmintákban. A CD25+ aktivált T sejtek prevalenciája 
magasabb volt PROM esetén. A CD4+ és CD8+ sejtek gyakorisága, valamint a 
CD4/CD8 arány alacsonyabb volt PE esetén. A CD62L+ T sejtek gyakorisága magasabb 
volt fiú, mint lány koraszülöttek esetén. A prenatális szteroid nem befolyásolta a 
vizsgált markereket. A CD4+ CD25+ sejtek prevalenciája alacsonyabb volt 
megszületéskor, mint a 7. életnapon. A Th2 sejtek gyakorisága alacsonyabb volt az 1. és 
3. életnapokon, mint a 7. életnapon. 
  
 Vizsgálati eredményeink új összefüggéseket tártak fel a koraszülöttek 
immunműködése és különböző perinatális szövődmények között, melyek a jövőben 
különböző diagnosztikus és terápiás módszerek kidolgozását segíthetik elő, javítva ezen 
sérülékeny populáció hosszú távú prognózisát. 
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